Phase 1 First-in-human Study of JS014

Clinical trial NCT05296772 · UNKNOWN

Trial details

NCT number: NCT05296772
Sponsor: Anwita Biosciences
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Malignant Neoplasm, Experimental Solid Tumor, Adult Lymphoma

Start date: 2022-02-28
Primary completion: 2024-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.